When Valisure tested ranitidine with salt concentrations approximating safe human ingestion levels ... The focus no longer was on whether the drug was dangerous. Now, it centered around claims of ...

Some top local politicians cut the ribbon Monday for a New Haven lab that works to test everyday products to make sure they ...

This is the usual safe harbor statement ... Turning to Slide 4. I will now hand the call to Emma. Welcome to everybody joining us today. Please turn to the next slide. I'm pleased to report ...

On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against ...

Q3 2024 Earnings Call Transcript October 30, 2024 GSK plc beats earnings expectations. Reported EPS is $1.29, expectations were $1.23. Operator: Hello, everyone. Welcome to today’s call and webcast.

1."A few years ago, I got a small cut on my knuckle. No big deal, right? It was just a small little nick; it didn't bleed ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

GSK has also reached an agreement to pay $70 million to resolve the Zantac Qui Tam suit previously ... To apply right now for a loan settlement program, please visit the company's website ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.